United Health Products Announces Henry Schien Halas as Exclusive Distributor

HENDERSON, NV--(Marketwired - May 3, 2016) - United Health Products, Inc. (OTCQB: UEEC) announced that they have signed Henry Schein Halas to an exclusive distribution agreement for all of United Health's HemoStyp® products in conjunction with an initial stocking order for Australia and the African Continent. Henry Schein Halas was formed in 2006, when two of Australia's most innovative and successful dental businesses joined together. Built on decades of service to the profession by Halas Dental Ltd and Henry Schein Regional Ltd, the company maintains strong Australian management together with the commitment and investment of Henry Schein, the world's leading dental distributor.

Their commitment to meeting and exceeding the service expectations of our customers is deeply ingrained in to their organization. Henry Schein currently supplies over 80% of all dental practices in Australia and New Zealand and has 18 distribution centers in the region. Henry Schein is also the number one supplier in Australia and New Zealand in the Veterinary market. Henry Schein currently supplies more than 70% of the market. 

About United Health Products Inc.
United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp®, is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products Inc. visit: www.unitedhealthproductsinc.com

Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.